XML 41 R32.htm IDEA: XBRL DOCUMENT v3.25.3
Share-Based Payment Arrangements (Tables)
9 Months Ended
Sep. 27, 2025
Schedule of Amounts Recognized in Financial Statements with Respect to Plans Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):
 
    
Thirty-Nine Weeks Ended
    
Thirteen Weeks Ended
 
    
September 27,

2025
    
September 28,

2024
    
September 27,

2025
    
September 28,

2024
 
Total cost of the Plans during the period
   $ 5,243      $ 3,573      $ 1,586      $ (43
Amount of related income tax benefit recognized during the period
     (1,179      (1,997      (387      (313
  
 
 
    
 
 
    
 
 
    
 
 
 
Net cost of the Plans during the period
   $ 4,064      $ 1,576      $ 1,199      $ (356
  
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of Information on Restricted Stock Units
The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:
 
    
Number of
RSUs
    
Weighted Average

Grant Date

Fair Value
 
Outstanding at December 28, 2024
     162,652      $ 144.12  
Granted
     53,930      $ 147.14  
Forfeited
     (8,653    $ 158.98  
  
 
 
    
Outstanding at September 27, 2025
     207,929      $ 144.29  
  
 
 
    
Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units
The following table summarizes information regarding the Company’s outstanding shares of
non-vested
restricted stock and Deferred Stock Units (defined below) under the Plans:
 
    
Number of Shares

and Deferred Stock
Units
    
Weighted Average

Grant Date

Fair Value
 
Non-vested
at December 28, 2024
     47,519      $ 180.17  
Granted
     30,149      $ 159.69  
Vested
     (23,950    $ 176.95  
Forfeited
     (661    $ 173.64  
  
 
 
    
Non-vested
at September 27, 2025
     53,057      $ 170.07